ANAB
AnaptysBio Inc
NASDAQ: ANAB · HEALTHCARE · BIOTECHNOLOGY
$65.73
+5.44% today
Updated 2026-04-30
Market cap
$1.81B
P/E ratio
—
P/S ratio
7.73x
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$11 – $72
Volume
0.6M
AnaptysBio Inc (ANAB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+62.0%
Last 4 quarters
Revenue YoY growth
+151.1%
Most recent quarter
EPS YoY growth
+319.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.7%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+11.9%
2026-03-09
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-09 | $1.58 | +81.1% | $55.41 | $62.01 | +11.9% |
| 2025-11-04 | $0.52 | +137.1% | $36.04 | $36.00 | -0.1% |
| 2025-08-07 | $-1.34 | +11.8% | $22.54 | $21.03 | -6.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.87 | $1.58 | +81.1% | $108.25M | +151.1% |
| 2025-09-30 | $-1.40 | $0.52 | +137.1% | $76.32M | +154.3% |
| 2025-06-30 | $-1.52 | $-1.34 | +11.8% | $22.26M | +102.9% |
| 2025-03-31 | $-1.56 | $-1.28 | +17.9% | $27.77M | +286.8% |
| 2024-12-31 | $-1.70 | $-0.72 | +57.8% | $43.11M | +378.8% |
| 2024-09-30 | $-1.65 | $-1.14 | +30.9% | $30.02M | +804.7% |
| 2024-06-30 | $-0.99 | $-1.71 | -72.7% | $10.97M | +217.1% |
| 2024-03-31 | $-1.57 | $-1.64 | -4.5% | $7.18M | — |
| 2023-12-31 | $-1.60 | $-1.59 | +0.6% | $9.01M | — |
| 2023-09-30 | $-1.79 | $-1.41 | +21.2% | $3.32M | — |
| 2023-06-30 | $-1.70 | $-1.50 | +11.8% | $3.46M | — |
Frequently asked questions
Has AnaptysBio Inc beaten earnings estimates?
AnaptysBio Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +62.0% over the last 4 quarters.
How does ANAB stock react to earnings?
ANAB stock has moved an average of +1.7% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is AnaptysBio Inc's revenue growth rate?
AnaptysBio Inc reported year-over-year revenue growth of +151.1% in its most recent quarter, with EPS growing +319.4% year-over-year.